Lowest Price Guaranteed From USD 1,899
Published
January 2022
Pages
121
View Count
7921
Example Insights
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
Report Description
Telehealth refers to the remote delivery of healthcare services, such as medical consults, examination / interpretation of medical reports, critical health parameter monitoring, medical information sharing (between physicians and their patients) and patient education, using modern telecommunications solutions. In other words, it offers a convenient and cost-effective way for individuals with health problems to seek medical attention from the comfort of their respective homes. Currently, a wide variety of virtual conferencing tools and intuitive software are available for the aforementioned purposes. In fact, during the COVID-19 pandemic, due to the enforcement of mandatory social distancing practices, a lot of routine and emergency medical consultations were reported to have been conducted in the virtual environment. In 2020, it was estimated that 76% of hospitals in the US were using diverse telehealth technologies to connect doctors to patients. Although the demand for and use of telehealth technologies witnessed a notable surge (experts believe that the use of such solutions increased by around 40% compared to the pre-COVID era) during the recent pandemic, the idea of remote delivery of medical advice / information is believed to have been conceived much earlier. It is, therefore, safe to infer that the pandemic served to provide a much-needed impetus to drive the adoption of remote medical services. Moreover, even as social distancing mandates are being revoked across the world, the expanded access to quality healthcare offered by telemedicine is anticipated to continue to be used at a less unprecedented but evident scale.
The recent years have witnessed a surge in investment activity in companies involved in the development of telehealth solutions. This was primarily fueled by the demand for remote healthcare services, which led to a marked increase in the adoption of various telemedicine, health tracking and medical information sharing products. According to one of our recent studies, many companies are also engaged in providing tailored solutions, along with remote access to medical care facilities to patients. In addition, around 90% of the healthcare organizations are believed to have already invested or have revealed strong intentions to invest in remote patient monitoring systems. In the wake of the recent increase in demand, we believe that the market presents lucrative investment opportunities for investors on the lookout for both short- and long-term gains.
The “Investor Series: Opportunities in the Telehealth Market” report provides detailed information on the telehealth industry, covering the core and peripheral products and affiliated services. It offers a technical and financial perspective on how the opportunity in this domain is likely to evolve, in terms of promising business ventures, over the coming decade. The information in this report has been presented across multiple deliverables, featuring interactive MS Excel sheets and an MS PowerPoint deck, which summarizes the key takeaways from the project, and insights drawn from the curated data. The report features the following details:
One of the key objectives of the report was to evaluate the current opportunity and the future potential of the site management organizations market over the coming decades. We have provided an informed estimate of the likely evolution of the market in the short to mid-term and long term, for the period 2021-2035. The opportunity has been segregated on the basis of [A] key market segments (namely telemedicine (which further includes interactive patient care, store & forward telemedicine and remote patient monitoring offerings), patient portals and tele-education) and [B] geography (North America, Europe, Asia Pacific and the rest of the world). To account for future uncertainties in the market and to add robustness to our model, we have provided three forecast scenarios, portraying the conservative, base and optimistic tracks of the market’s evolution.
Contents
Excel Deliverables
Sheet I includes details on the key innovator companies captured in the report along with a summary dashboard, featuring interactive graphical representations of key insights generated from the company health indexing, value proposition analysis and company competitiveness analysis. This sheet also includes details of our proprietary key acquisition targets analysis.
Sheet II features a summary dashboard, including interactive graphical representations of some of the key insights generated related to the capital investments made in telehealth (since 2011) and our proprietary company valuation analysis (focused on the key innovator companies that have not yet gone public).
Sheet III is a summary of insights generated from a detailed fundamental and technical financial analysis, of publicly listed ventures in the key innovators dataset. It also offers a pictorial perspective on some of the major areas of risk associated with telehealth. It is worth mentioning that for each company, there is a separate MS Excel sheet, which provides information on key financial parameters and competitive insights based on historical and prevalent trends.
Sheet IV is a summary MS Excel dashboard, offering detailed graphical representations of the contemporary and future opportunity associated with telehealth. It also includes a collection of publicly available information on the investments made by select investors in companies that are now publicly listed. Based on the aforementioned information, the sheet offers a proprietary perspective on likely returns on investment received by the mentioned investors.
PowerPoint Deliverable: Key Section Outlines
Section I describes the current need for telehealth solutions and services, highlighting some of their key application areas. It includes information on the various companies that are engaged in this domain, along with details of some exemplary ventures that have either succeeded or failed in this market. It also features inputs from representatives from key stakeholder companies in this domain (as stated in publicly available articles and interview transcripts). The section concludes with information on the different conferences that have been conducted in this domain in the recent past.
The section also provides a [A] detailed analysis of telehealth focused innovator companies that were established on or after 2005. The section features basic company related details, such as year of establishment, headquarters, company size, and type of venture. It also includes [B] information on the various products and affiliated services, including analysis based on number and type of product, which are offered by the aforementioned companies. Based on the abovementioned insights, it offers a [C] quantitative perspective on the relative health (based on basic company details, product details, financing activity, and estimated revenues and profits) of the different innovator companies. In addition, it offers an informed perspective on the key [D] value proposition of the same companies based on multiple relevant aspects, namely applicability and adoption trends, treatment-related value, value to patients, value to patients and healthcare professionals, and others. Finally, based on the aforementioned inputs, the section features a detailed [E] company competitiveness analysis, offering a quantitative basis for comparing the diverse telehealth solutions captured in this report. It is worth mentioning that the analysis described in this section is based on proprietary scoring criteria, which was informed via secondary research.
Section II offers insights from a detailed [A] analysis of the funding and investment activity that has taken place in this domain, since 2011. It also includes financing category-wise trends, describing the relative maturity (in terms of number of funding instances and total capital raised) of the key innovator companies discussed in the report. Further, it features a proprietary basis for [B] estimating the relative valuation of the private companies among the key innovators discussed in this report. It is worth mentioning that the aforementioned estimations were based on information gathered via secondary research, for a sample set of companies. Key inferences drawn from the sample set were extrapolated using the appropriate mathematical models to generate valuation estimates for all companies in the dataset.
Section III is modelled in the likeness of an equity research report. It features a review of the overall telehealth market from a financial perspective and includes detailed fundamental (insights from the balance sheet, and key financial ratios) and technical analyses (insights from historical and recent stock price variations, and analysis using popular stock performance indicators) of financial data of six of the publicly listed companies within the key innovators dataset.
Section IV includes a business risk analysis, offering insights encompassing several known categories of risk; these include operations-related risks, business-related risks, product / technology risks, financial / asset-related risks, and other risks.
Section V features is an insightful market forecast analysis, highlighting the estimated current and future sizes of overall telehealth market till the year 2035. The opportunity has been segregated on the basis of [A] key market segments (namely telemedicine (which further includes interactive patient care, store & forward telemedicine and remote patient monitoring offerings), patient portals and tele-education) and [B] geography (North America, Europe, Asia Pacific and the rest of the world). It also includes case studies of instances where investors have exited various telehealth-related ventures, offering insights on returns on investment made (based on availability of data). Based on the abovementioned details, it provided an informed opinion on the future outlook for investors in the telehealth market.
Section VI offers insights from a proprietary analysis that leverages inputs from the startup health indexing and value proposition analysis (described in section I), to offer qualitative recommendations on companies that are likely to be perceived as key acquisition targets.
Excel Deliverable
1. Key Innovators Dataset
1.1. Summary Dashboard
1.2. Key Innovators Dataset
1.3. Telehealth Products Dataset
1.4. Company Health Indexing
1.5. Value Proposition Analysis
1.6. Company Competitiveness Analysis
1.7. Key Acquisition Targets
2. Analysis of Funding & Company Valuation
2.1. Summary Dashboard
2.2. Capital Investments in Telehealth
2.3. Company Valuation Analysis
3. Fundamental & Technical Financial Analysis
3.1. Summary Dashboard
3.2. Business Risk Analysis
4. Opportunity Analysis & Mapping Key Investor Exits
4.1. Summary Dashboard
4.2. Market Forecast & Opportunity Analysis
4.3. Analysis of Key Investor Exits
PowerPoint Deliverable
1. Context
2. Project Approach
3. Project Objectives
4. Executive Summary
Section I: Need for Telehealth Solutions & Key Innovators Landscape
5. Contemporary Telehealth Market
5.1. Need for Telehealth Solutions / Services
5.2. Industry Expert Perspective
5.3. Key Initiatives in Telehealth (Case Studies)
5.3.1. Exemplary Business Successes
5.3.2. Exemplary Business Failures
5.4. Analysis of Recent Conferences
6. Key Innovators Market Landscape
6.1. Overview
6.2. Key Innovators in Telehealth
6.2.1. Analysis by Year of Establishment
6.2.2. Analysis by Company Size
6.2.3. Analysis by Type / Stage of Venture
6.2.4. Analysis by Geographical Location
6.3. Concluding Remarks
7. Key Products Landscape
7.1. Overview
7.2. Telehealth Products and Affiliated Services
7.2.1. Analysis by Type of Product
7.2.2. Analysis by
7.3. Concluding Remarks
8. Company Health Indexing and Value Proposition Analysis
8.1. Overview
8.2. Company Health Indexing
8.3. Value Proposition Analysis
8.4. Company Competitiveness Analysis
8.5. Concluding Remarks
Section II Analysis of Investments & Company Valuation
9. Funding and Investments Analysis
9.1. Overview of Funding Activity, 2011-2021
9.1.1. Analysis by Year of Funding
9.1.2. Analysis by Type of Funding
9.1.3. Analysis by Type of Funding and Amount Invested
9.1.4. Funding and Investments Summary
10. Company Valuation Analysis
10.1. Overview
10.2. Valuation Analysis
10.2.1. Approach 1: Based on Estimated Valuation
10.2.2. Approach 2: Based on Estimated Value and Revenues
10.2.3. Approach 3: Based on Stage of Financing
10.3. Conclusion
Section III Fundamental & Technical Financial Analysis
11. Financial Analysis of Public Ventures
11.1. Overview
11.2. 23andMe
11.2.1. Fundamental Analysis of Company Financials
11.2.1.1. Insights from Balance Sheet
11.2.1.2. Analysis of Financial Ratios
11.2.2. Technical Analysis of Stock Price
11.2.2.1. Historical Trends
11.2.2.2. Recent Trends
11.3. Accolade
11.3.1. Fundamental Analysis of Company Financials
11.3.1.1. Insights from Balance Sheet
11.3.1.2. Analysis of Financial Ratios
11.3.2. Technical Analysis of Stock Price
11.3.2.1. Historical Trends
11.3.2.2. Recent Trends
11.4. Amwell
11.4.1. Fundamental Analysis of Company Financials
11.4.1.1. Insights from Balance Sheet
11.4.1.2 Analysis of Financial Ratios
11.4.2. Technical Analysis of Stock Price
11.4.2.1. Historical Trends
11.4.2.2. Recent Trends
11.5. Dialogue
11.5.1. Fundamental Analysis of Company Financials
11.5.1.1. Insights from Balance Sheet
11.5.1.2. Analysis of Financial Ratios
11.5.2. Technical Analysis of Stock Price
11.5.2.1. Historical Trends
11.5.2.2.Recent Trends
11.6. Talkspace
11.6.1. Fundamental Analysis of Company Financials
11.6.1.1. Insights from Balance Sheet
11.6.1.2. Analysis of Financial Ratios
11.6.2. Technical Analysis of Stock Price
11.6.2.1. Historical Trends
11.6.2.2. Recent Trends
11.7. Teladoc Health
11.7.1. Fundamental Analysis of Company Financials
11.7.1.1. Insights from Balance Sheet
11.7.1.2. Analysis of Financial Ratios
11.7.2. Technical Analysis of Stock Price
11.7.2.1. Historical Trends
11.7.2.2. Recent Trends
Section IV Business Risk Analysis
12. Risk Analysis of Public Companies
12.1. Overview
12.2. Business Risk Analysis
12.2.1. Operations-related Risks
12.2.2. Business-related Risks
12.2.3. Product / Technology Risks
12.2.4. Financial / Asset-related Risks
12.2.5. Other Risks
12.3. Concluding Remarks
Section V Opportunity Analysis & Mapping Key Investor Exits
13. Market Forecast and Opportunity Analysis
13.1. Overview and Methodology
13.2. Overall Telehealth Market Size, 2021-2035
13.2.1. Analysis by Key Market Segments
13.2.2. Analysis by Geography
13.2.3. Concluding Remarks
14. Investor Exits & Estimated Returns on Investment
14.1. Outlook for Investors
14.2. Publicly Disclosed Investor Exits
14.2.1. Estimated Returns on Investment
14.3. Concluding Remarks
15. Key Acquisition Targets
15.1. Overview
15.2. Analysis of Key Acquisition Targets
15.3. Concluding Remarks
16. Appendices I: Tabulated Data
17. Appendices II: List of Companies & Organizations
The following companies and organizations have been mentioned in the report.
Source: www.health.harvard.edu/staying-healthy/telehealth-the-advantages-and-disadvantages
PRICING DETAILS
Discounts available for multiple report purchases
sales@rootsanalysis.com
YOU MAY ALSO LIKE
SUBSCRIBE TO INDUSTRY UPDATES